GERN - Geron Corporation - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.552B

Cash

380.7M

Avg Qtr Burn

-34.94M

Short % of Float

4.56%

Insider Ownership

0.13%

Institutional Own.

44.85%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Imetelstat (GRN163L) Details Hematologic malignancies, Myelodysplastic syndrome	NDA Submission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Imetelstat (GRN163L) Details MF (Myelofibrosis)	Phase 3 Interim Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.